Xarelto | The American Association For Justice



Xarelto® is one of several new prescription blood thinning medications introduced in recent years as an alternative to Coumadin® (warfarin sodium) as it does not require routine blood monitoring during treatment. However, use of Xarelto® causes serious and uncontrolled internal bleeding, which results in life-threatening injuries or death. There is currently no anticoagulant solution to stop bleeding complications that may develop among users.

The Xarelto® Litigation Group was founded for members to exchange knowledge and information and to provide opportunities for informational meetings and education programs regarding the Xarelto® litigation. The Xarelto® Litigation Group will also offer assistance and guidance in regard to the coordination of a future MDL and state court litigations. 


This Litigation Group was formed in July 2014.

Benefits & Resources:

The Xarelto® Litigation Group has a secure list server and a document library where members can share information, documents, and pertinent information as well as holds education programs.


AAJ Annual and Winter Conventions, or as needed by group members.

Roger C. Denton
Schlichter Bogard & Denton
100 S. 4th St., Suite 1200
Saint Louis, MO 63102
Phone: 314/621-6115
Fax: 314/621-7151
Neil E. McWilliams
Levin, Papantonio, Thomas, Mitchell, Rafferty &
Proctor, PA
316 S. Baylen St., Suite 600
Pensacola, FL 32502
Phone: 850/435-7165
Fax: 850/436-6165
PDF Application:
$300/attorney, $100/additional attorney ($500 max)